Hospitalized patients with stress hyperglycemia: incidence of diabetes and mortality on follow-up
Endocrinol Diabetes Nutr (Engl Ed). 2018 Dec;65(10):571-576.
doi: 10.1016/j.endinu.2018.07.005.
Epub 2018 Oct 4.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Electronic address: paula.russo@hospitalitaliano.org.ar.
- 2 Área de Investigación en Medicina Interna, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Servicio Medicina Familiar y Comunitaria, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Área Epidemiológica de Dirección de Promoción de la Salud y Control de Enfermedades No Transmisibles, Ministerio de Salud de Nación, Argentina.
- 3 Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Área de Investigación en Medicina Interna, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Departamento de Investigación, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
- 4 Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Área de Investigación en Medicina Interna, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Abstract
Introduction:
The study objective was to estimate during post-discharge follow-up the incidence of diabetes and to ascertain mortality in hospitalized patients, classified during follow-up as having stress hyperglycemia (SH) or normoglycemia (NG) based on blood glucose levels.
Material and methods:
A retrospective cohort of non-diabetic adults with SH (> 140mg/dl and HbA1c <6.5%) or NG (all blood glucose values ≤ 140mg/dl) was used.
Results:
There were 3981 patients with NG and 884 with SH. During the observation period (median follow-up of 1.83 years), there were 255 cases of diabetes and 831 deaths. The cumulative incidence of diabetes per year was 1.59% (95% CI: 1.23-2.06) in patients with NG and 7.39% (95% CI: 5.70-9.56) in those with SH. SH was significantly associated to diabetes (crude HR 1.33, 95% CI: 1.13-1.73, p .025), even after adjusting for age and sex (adjusted HR 1.38, 95% CI 1.06-1.78, p .014). The mortality rate at one year was 10.07% (95% CI: 9.18-11.05) in NG patients and 13.24% (95% CI: 11.17-15.65) in SH patients. The sub-hazard ratio of developing diabetes considering death as a competitive event was 1.41 (95% CI 1.29-1.53, p <.001).
Conclusions:
SH is a risk factor for diabetes. There were no differences in mortality during follow-up, but death appears to be a competitive event in development of diabetes in this population.
Keywords:
Diabetes; Hiperglucemia de estrés; Mortalidad; Mortality; Stress hyperglycemia.
Copyright © 2018 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Argentina / epidemiology
-
Diabetes Mellitus / epidemiology*
-
Diagnosis-Related Groups
-
Female
-
Follow-Up Studies
-
Glycated Hemoglobin / analysis
-
Hospital Mortality*
-
Hospitalization
-
Hospitals, University / statistics & numerical data
-
Humans
-
Hyperglycemia / epidemiology*
-
Hyperglycemia / etiology
-
Incidence
-
Inpatients*
-
Kaplan-Meier Estimate
-
Length of Stay / statistics & numerical data
-
Male
-
Middle Aged
-
Proportional Hazards Models
-
Retrospective Studies
-
Risk Factors
-
Stress, Physiological*
-
Tertiary Care Centers / statistics & numerical data